Group One Trading’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,418
| Closed | -$370K | – | 7844 |
|
|
2026
Q1 | $354K | Buy |
+4,418
| New | +$364K | ﹤0.01% | 3655 |
|
|
2025
Q3 | – | Sell |
-4,331
| Closed | -$338K | – | 8587 |
|
|
2025
Q2 | $339K | Buy |
+4,331
| New | +$323K | ﹤0.01% | 3799 |
|
|
2025
Q1 | – | Sell |
-53,793
| Closed | -$3.85M | – | 7806 |
|
|
2024
Q4 | $3.98M | Buy |
53,793
+29,435
| +121% | +$2.06M | 0.01% | 1327 |
|
|
2024
Q3 | $1.61M | Buy |
24,358
+1,398
| +6% | +$102K | ﹤0.01% | 1899 |
|
|
2024
Q2 | $2.12M | Buy |
22,960
+2,003
| +10% | +$177K | 0.01% | 1408 |
|
|
2024
Q1 | $2M | Buy |
20,957
+3,797
| +22% | +$319K | 0.01% | 1480 |
|
|
2023
Q4 | $1.31M | Sell |
17,160
-3,609
| -17% | -$251K | ﹤0.01% | 2215 |
|
|
2023
Q3 | $1.44M | Buy |
20,769
+16,208
| +355% | +$1.3M | ﹤0.01% | 1918 |
|
|
2023
Q2 | $430K | Buy |
+4,561
| New | +$396K | ﹤0.01% | 3176 |
|
|
2021
Q4 | – | Sell |
-18,878
| Closed | -$2.2M | – | 8370 |
|
|
2021
Q3 | $2.14M | Buy |
18,878
+5,200
| +38% | +$594K | ﹤0.01% | 2583 |
|
|
2021
Q2 | $1.42M | Sell |
13,678
-3,800
| -22% | -$358K | ﹤0.01% | 3013 |
|
|
2021
Q1 | $1.46M | Sell |
17,478
-5,561
| -24% | -$470K | ﹤0.01% | 2793 |
|
|
2020
Q4 | $2.1M | Buy |
+23,039
| New | +$1.91M | ﹤0.01% | 2007 |
|
|
2020
Q3 | – | Sell |
-4,921
| Closed | -$384K | – | 6209 |
|
|
2020
Q2 | $340K | Buy |
+4,921
| New | +$350K | ﹤0.01% | 2935 |
|
|
2019
Q4 | – | Sell |
-1,557
| Closed | -$122K | – | 5231 |
|
|
2019
Q3 | $114K | Buy |
+1,557
| New | +$109K | ﹤0.01% | 3471 |
|
|
2019
Q1 | – | Sell |
-4,725
| Closed | -$270K | – | 4962 |
|
|
2018
Q4 | $241K | Buy |
+4,725
| New | +$239K | ﹤0.01% | 2532 |
|
|
2018
Q1 | – | Sell |
-1,632
| Closed | -$70.9K | – | 4957 |
|
|
2017
Q4 | $61K | Sell |
1,632
-3,462
| -68% | -$127K | ﹤0.01% | 3618 |
|
|
2017
Q3 | $186K | Sell |
5,094
-5,904
| -54% | -$225K | ﹤0.01% | 2807 |
|
|
2017
Q2 | $433K | Sell |
10,998
-7,572
| -41% | -$276K | ﹤0.01% | 2073 |
|
|
2017
Q1 | $582K | Buy |
18,570
+16,062
| +640% | +$503K | 0.01% | 1743 |
|
|
2016
Q4 | $78K | Buy |
2,508
+120
| +5% | +$3.89K | ﹤0.01% | 2992 |
|
|
2016
Q3 | $96K | Sell |
2,388
-5,769
| -71% | -$217K | ﹤0.01% | 2950 |
|
|
2016
Q2 | $271K | Sell |
8,157
-8,280
| -50% | -$283K | ﹤0.01% | 2193 |
|
|
2016
Q1 | $483K | Buy |
+16,437
| New | +$454K | 0.01% | 1711 |
|
|
2014
Q2 | – | Sell |
-5,940
| Closed | -$80.5K | – | 5241 |
|
|
2014
Q1 | $73K | Buy |
5,940
+300
| +5% | +$3.46K | ﹤0.01% | 3335 |
|
|
2013
Q4 | $62K | Sell |
5,640
-30,666
| -84% | -$346K | ﹤0.01% | 3430 |
|
|
2013
Q3 | $421K | Buy |
36,306
+15,708
| +76% | +$184K | 0.01% | 1769 |
|
|
2013
Q2 | $231K | Buy |
+20,598
| New | +$244K | 0.01% | 2043 |
|
Other funds holding EW
Group One Trading's EW Position: Q2 2026 in Review
Group One Trading sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 4,418 shares — an estimated $370K sold.
Group One Trading first reported a position in EW in Q2 2013 and held it in 28 quarters. The position peaked at $3.98M in Q4 2024. 1,337 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Group One Trading reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
- Group One Trading sold 4,418 Edwards Lifesciences shares in Q2 2026, an estimated $370K.
- Group One Trading first reported a position in Edwards Lifesciences in Q2 2013 and held it in 28 quarters.
- Group One Trading's Edwards Lifesciences position peaked at $3.98M in Q4 2024.
- 1,337 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.